Maffei, FA, Heine, RP, Whalen, MJ, Mortimer, LF, and Carcillo, JA. "Levels of antimicrobial molecules defensin and lactoferrin are elevated in the cerebrospinal fluid of children with meningitis." Pediatrics 103, no. 5 I (1999): 987-992.
Robert Phillips Heine, MD
Dr. R. Phillips Heine is a Professor of Obstetrics & Gynecology and Pediatrics at Duke University Medical Center in Durham, NC. He currently serves as the Director of the Division of Maternal-Fetal Medicine, Vice Chair for Administration Affairs, and Medical Director for the Women’s Clinical Services Unit (CSU) in the Duke University Health System.
Dr. Heine completed his clinical training in Obstetrics and Gynecology at the University of North Carolina during which time he developed an academic interest regarding infection and its role in women’s reproductive health and specifically adverse pregnancy outcome. He subsequently completed a Sexually Transmitted Diseases research fellowship in the laboratories of Fred Sparling and Priscilla Wyrick at the University of North Carolina and went on to complete a Maternal-Fetal Medicine fellowship at the University of Colorado. After fellowship Dr. Heine became a faculty member at the University of Pittsburgh and an investigator at the Magee Women’s Research Institute. During this time he served as Resident Research Coordinator and Associate MFM fellowship director prior to his move to Duke University.
His current clinical and research interests focus on the role of infection and inflammation in preterm birth and other adverse pregnancy outcomes. He also has a specific interest in the use of immunizations in pregnancy for both the prevention of disease in the mother and the newborn.
Education and Training
- Fellow, Obstetrics & Gynecology, University of Colorado at Boulder, 1991 - 1993
- Fellow, Obstetrics & Gynecology, North Carolina Memorial Hospital, 1990 - 1991
- Resident, Obstetrics & Gynecology, North Carolina Memorial Hospital, 1986 - 1990
- M.D., Texas Tech University of Health Science Nursing, 1986
Selected Grants and Awards
- VTEU Task C Option 1 - FY.2017.B2C2D2.0053
- VTEU Task C Option 4 - FY.2017.B2C2D2.0053
- VTEU Task C Option 3 - FY.2017.B2C2D2.0053
- VTEU 12-0021 Task C - Base
- VTEU Task C Option 2 - FY.2017.B2C2D2.0053
- CISA: 2015 CISA 03 - Lead Site Base Task: Maternal Tdap and IIV Study (Lead)
- VTEU 12-0021 - Task C Option 1
- CISA Task Order No. 3 Tdap Safety in Pregnant Women
- Role of GRK6-Mediated Oxytocin Receptor Desensitization in Labor
- Effectiveness of a Vaccination Program in the Community ObGyn Setting
Sunyecz, JA, Wiesenfeld, HC, and Heine, RP. "The pharmacokinetics of once-daily dosing with gentamicin in women with postpartum endometritis." November 17, 1998.
Wiesenfeld, HC, and Heine, RP. "The use of once-daily dosing of gentamicin in obstetrics and gynecology." November 17, 1998.
Heine, RP, Wiesenfeld, H, Mortimer, L, and Greig, PC. "Amniotic fluid defensins: potential markers of subclinical intrauterine infection." Clin Infect Dis 27, no. 3 (September 1998): 513-518.
Draper, D, Donohoe, W, Mortimer, L, and Heine, RP. "Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor." J Infect Dis 178, no. 3 (September 1998): 815-819.
Ness, RB, McLaughlin, MT, Heine, RP, Bass, DC, and Mortimer, L. "Fetal fibronectin as a marker to discriminate between ectopic and intrauterine pregnancies." Am J Obstet Gynecol 179, no. 3 Pt 1 (September 1998): 697-702.
Ness, RB, McLaughlin, MT, Heine, RP, Bass, DC, and Mortimer, L. "Fetal fibronectin as a marker to discriminate between ectopic and intrauterine pregnancies." American Journal of Obstetrics and Gynecology 179, no. 3 I (1998): 697-702.
Sunyecz, JA, Wiesenfeld, HC, and Heine, RP. "The pharmacokinetics of once-daily dosing with gentamicin in women with postpartum endometritis." Infect Dis Obstet Gynecol 6, no. 4 (1998): 160-162.
Wiesenfeld, HC, and Heine, RP. "The use of once-daily dosing of gentamicin in obstetrics and gynecology." Infect Dis Obstet Gynecol 6, no. 4 (1998): 155-159. (Review)
Heine, RP, Wiesenfeld, HC, and Sweet, RL. "The vagina is an effective sampling site for Neisseria gonorrhoeae testing by polymerase chain reaction." Infectious Diseases in Clinical Practice 7, no. 9 (1998): 488-490.